Noticias de Eulerpool PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Eulerpool-AFX

PhaseBio Pharmaceuticals Noticias de Acciones

PhaseBio Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de PhaseBio Pharmaceuticals.

• 12 de febrero ·

  Seeking Alpha
  Week In Review: CANbridge In-Licenses Gene Therapy For Rare Disease From UMass
• 7 de noviembre ·

  MarketWatch
  Bankrupt PhaseBio Identifies Chiesi as Lead Bidder for Bentracimab Assets
• 24 de octubre ·

  Business Wire
  PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
• 12 de agosto ·

  Business Wire
  PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights